基本信息
浏览量:304
职业迁徙
个人简介
I am a professor in the Department of Obstetrics and Gynecology at The Ohio State University College of Medicine and the director of the Division of Gynecologic Oncology at the OSUCCC – James, where I've been a faculty member since 2005. I completed my gynecologic oncology fellowship at Yale University and my residency at Case Western Reserve University (MetroHealth) and the Cleveland Clinic Foundation. I attended medical school at Wayne State and earned my undergraduate degree at the University of Notre Dame.
I am the director for clinical research in gynecologic oncology, as well as the co-director of the gynecologic oncology phase I program. I also serve as the ORIEN physician liaison for The Ohio State University Comprehensive Cancer Center. I am active nationally as a committee member for the NCI Gynecologic Cancer Steering Committee’s Ovarian Task Force, NRG Oncology (Ovarian Cancer and Developmental Therapeutics Groups), the Society of Gynecologist Oncology and the American Society of Clinical Oncology. My passion for improving the care of patients with gynecologic cancers and my expertise in ovarian cancer resulted in my appointment to the panel of the National Comprehensive Cancer Network (NCCN) Guidelines for Ovarian Cancer, where I continue as an active participant.
As a member of the Translational Therapeutics Program at the OSUCCC – James, my research is focused on identifying novel and innovative therapies for gynecologic cancers. I have designed, coordinated and published on all levels of clinical trials to include phase I, II and III studies with a special interest in novel compounds. I continue to work to improve the therapies (novel techniques/targets/immune therapy) as well as identify patients who would benefit (or not benefit) from different treatment options in ovarian and uterine cancer (specifically high-risk histologies) while minimizing side effects.
The quest to improve patient outcomes has led me to my work on improving surgical techniques. Robotic-assisted, minimally invasive surgical techniques have been implemented in all aspects of practice, resulting in the publication of the improved outcomes and as an instructor on these techniques at a national level.
I am honored and humbled to help care for the amazing women who are my patients and their families. Improving the care of women with gynecologic cancer through research has led to me being recognized with over 100 publications in the most respected scientific journals, including New England Journal of Medicine, Journal of Clinical Oncology, Lancet Oncology, JAMA Oncology and Nature Genetics.
My compassionate nature and communication has been recognized with patient satisfaction that ranks at the very top for the country. My accomplishments have also resulted in being named as one of the Best/Top Doctors in America by U.S. News and World Report (Castle Connelly) and Best Doctors for multiple years. However, my greatest pride comes from my family, including my beautiful wife and our five amazing children.
I am the director for clinical research in gynecologic oncology, as well as the co-director of the gynecologic oncology phase I program. I also serve as the ORIEN physician liaison for The Ohio State University Comprehensive Cancer Center. I am active nationally as a committee member for the NCI Gynecologic Cancer Steering Committee’s Ovarian Task Force, NRG Oncology (Ovarian Cancer and Developmental Therapeutics Groups), the Society of Gynecologist Oncology and the American Society of Clinical Oncology. My passion for improving the care of patients with gynecologic cancers and my expertise in ovarian cancer resulted in my appointment to the panel of the National Comprehensive Cancer Network (NCCN) Guidelines for Ovarian Cancer, where I continue as an active participant.
As a member of the Translational Therapeutics Program at the OSUCCC – James, my research is focused on identifying novel and innovative therapies for gynecologic cancers. I have designed, coordinated and published on all levels of clinical trials to include phase I, II and III studies with a special interest in novel compounds. I continue to work to improve the therapies (novel techniques/targets/immune therapy) as well as identify patients who would benefit (or not benefit) from different treatment options in ovarian and uterine cancer (specifically high-risk histologies) while minimizing side effects.
The quest to improve patient outcomes has led me to my work on improving surgical techniques. Robotic-assisted, minimally invasive surgical techniques have been implemented in all aspects of practice, resulting in the publication of the improved outcomes and as an instructor on these techniques at a national level.
I am honored and humbled to help care for the amazing women who are my patients and their families. Improving the care of women with gynecologic cancer through research has led to me being recognized with over 100 publications in the most respected scientific journals, including New England Journal of Medicine, Journal of Clinical Oncology, Lancet Oncology, JAMA Oncology and Nature Genetics.
My compassionate nature and communication has been recognized with patient satisfaction that ranks at the very top for the country. My accomplishments have also resulted in being named as one of the Best/Top Doctors in America by U.S. News and World Report (Castle Connelly) and Best Doctors for multiple years. However, my greatest pride comes from my family, including my beautiful wife and our five amazing children.
研究兴趣
论文共 532 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Gynecologic Oncology (2024): 186-193
David Mutch, Athina Voulgari, Xian (Marissa) Chen,William H. Bradley,Ana Oaknin,Jose Alejandro Perez Fidalgo, Fernando Galvez Montosa,Antonio Casado Herraez,Robert W. Holloway,Matthew A. Powell, Malgorzata Nowicka,Gabriele Schaefer,
CANCER (2024)
Julia Chalif, Heather Wang,Daniel Spakowicz, Allison Quick, Elizabeth K. Arthur,David O'Malley,Laura M. Chambers
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCERno. 2 (2024): 317-327
Clinical cancer research : an official journal of the American Association for Cancer Researchno. 1 (2024): 50-62
Gynecologic oncology (2023): 15-21
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)
引用0浏览0引用
0
0
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): 5515-5515
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn